{"title":"Feasibility of a breath robot intervention to reduce sleep problems in posttraumatic stress disorder: A randomized controlled study","authors":"Annett Lotzin , Carlotta Reinhardt , Michael Barthelmäs , Isabelle Laskowsky","doi":"10.1016/j.ijchp.2025.100594","DOIUrl":null,"url":null,"abstract":"<div><div>Background: Patients with Posttraumatic stress disorder (PTSD) suffer from sleep problems. Robot interventions offer a novel approach to reducing these problems. However, it is unclear whether patients with PTSD accept and regularly use a robot intervention and whether it is effective. Objective: This randomized controlled study evaluated the feasibility of a novel breath robot intervention in PTSD patients. Methods: Thirty-one adults with PTSD according to DSM-V (PSSI-5) with impaired sleep (PSQI > 5) were randomly assigned to a 4-week robot intervention (Somnox 2) with human breath simulation or to a 4-week robot intervention without human breath simulation. The primary feasibility outcome was the proportion of randomized participants providing outcome data at post-treatment. Secondary feasibility outcomes involved eligibility rate, recruitment speed, uptake, retention, treatment adherence, and dropout, clinical outcomes included sleep quality (PSQI), PTSD symptoms (PSSI-5), distress (PSS-10), and well-being (WHO-5). Results: Outcome data were provided by 96.8 %; eligibility rate was 75.6 %; 31 patients were recruited within 6 months; uptake and retention were 100 %; treatment adherence was 93.8 % in the intervention and 92.9 % in the active control group; dropout was 0 %. Distress decreased significantly more in the intervention group compared to the active control group (<em>SMD =</em> 0.67, 95 % CI 0.39, 0.94), but sleep quality, PTSD symptoms, and well-being did not improve significantly more. Conclusions: The use of a 4-week breath robot intervention was feasible and highly accepted in patients with severe PTSD. The breath robot intervention may reduce distress but may not be superior to a robot intervention without breath simulation for improving sleep and PTSD symptoms. Future trials should further determine the intervention’s clinical benefit.</div></div>","PeriodicalId":47673,"journal":{"name":"International Journal of Clinical and Health Psychology","volume":"25 2","pages":"Article 100594"},"PeriodicalIF":4.4000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical and Health Psychology","FirstCategoryId":"102","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1697260025000523","RegionNum":1,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Patients with Posttraumatic stress disorder (PTSD) suffer from sleep problems. Robot interventions offer a novel approach to reducing these problems. However, it is unclear whether patients with PTSD accept and regularly use a robot intervention and whether it is effective. Objective: This randomized controlled study evaluated the feasibility of a novel breath robot intervention in PTSD patients. Methods: Thirty-one adults with PTSD according to DSM-V (PSSI-5) with impaired sleep (PSQI > 5) were randomly assigned to a 4-week robot intervention (Somnox 2) with human breath simulation or to a 4-week robot intervention without human breath simulation. The primary feasibility outcome was the proportion of randomized participants providing outcome data at post-treatment. Secondary feasibility outcomes involved eligibility rate, recruitment speed, uptake, retention, treatment adherence, and dropout, clinical outcomes included sleep quality (PSQI), PTSD symptoms (PSSI-5), distress (PSS-10), and well-being (WHO-5). Results: Outcome data were provided by 96.8 %; eligibility rate was 75.6 %; 31 patients were recruited within 6 months; uptake and retention were 100 %; treatment adherence was 93.8 % in the intervention and 92.9 % in the active control group; dropout was 0 %. Distress decreased significantly more in the intervention group compared to the active control group (SMD = 0.67, 95 % CI 0.39, 0.94), but sleep quality, PTSD symptoms, and well-being did not improve significantly more. Conclusions: The use of a 4-week breath robot intervention was feasible and highly accepted in patients with severe PTSD. The breath robot intervention may reduce distress but may not be superior to a robot intervention without breath simulation for improving sleep and PTSD symptoms. Future trials should further determine the intervention’s clinical benefit.
期刊介绍:
The International Journal of Clinical and Health Psychology is dedicated to publishing manuscripts with a strong emphasis on both basic and applied research, encompassing experimental, clinical, and theoretical contributions that advance the fields of Clinical and Health Psychology. With a focus on four core domains—clinical psychology and psychotherapy, psychopathology, health psychology, and clinical neurosciences—the IJCHP seeks to provide a comprehensive platform for scholarly discourse and innovation. The journal accepts Original Articles (empirical studies) and Review Articles. Manuscripts submitted to IJCHP should be original and not previously published or under consideration elsewhere. All signing authors must unanimously agree on the submitted version of the manuscript. By submitting their work, authors agree to transfer their copyrights to the Journal for the duration of the editorial process.